Morag Park

"The Gairdner Foundation exists to find the science that will matter most to human health, and to inspire the next generation of scientists to pursue it. That mission has never felt more urgent. I am honoured to lead an organization with this extraordinary reach and an important record of recognizing excellence before the rest of the world does." — Dr. Morag Park

The Gairdner Foundation welcomes Dr. Morag Park as its new President and Scientific Director effective June 1, 2026.

An internationally recognized cancer researcher and scientific leader, her discoveries have advanced precision oncology and transformed our understanding of breast cancer. A distinguished James McGill Professor and former holder of the Diane and Sal Guerrera Chair in Cancer Genetics at McGill University's Rosalind and Morris Goodman Cancer Institute, her pioneering research on the MET receptor helped lay the foundation for targeted cancer therapies used worldwide.

Beyond her scientific contributions, Dr. Park has played a leading role in shaping Canada's research ecosystem through senior leadership positions with the Canadian Institutes of Health Research and the Canadian Cancer Research Alliance. A Fellow of the Royal Society of Canada, Knight of the Ordre national du Québec, and 2026 inductee into the Canadian Medical Hall of Fame, she has built and led research programs that have influenced cancer research in Canada and around the world.